Jerry Colca

Metabolic Solutions Development Company is an emerging biopharmaceutical company developing first in class oral therapeutics to treat diseases associated with metabolic dysfunction, including NASH, polycystic kidney disease, and diabetes, as well as neurodegenerative diseases such as Alzheimer's and Parkinson's disease.